Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Abstract Introduction: Pregabalin, a new-generation epilepsy drug, is a structural analog of GABA, whose method of treatment is not fully know. Sudden removal syndrome occurs when the drug is suspended for at least a week, causing an abstinence syndrome. Case: A 97 –year-old woman with diabetic neuropathy being treated with pregabalin for 4 years stopped taking the drug 4 days prior to being admitted to the hospital. She was suffering from weakness, paresthesia, myalgia in her limbs, profuse sweating and psychomotor agitation. Other causes were dismissed because she started taking pregabalin again and the symptoms disappeared within a week. Discusion: Sudden removal of pregabalin syndrome, is a rare condition that occurs when the drug, is no longer taken. In less than a week, various symptoms appear which later disappear after resuming taking the drug.
Agency European Medicines. Ficha técnica de Pregabalina. [Online]; 2015. Available from: http://www.ema.europa.eu
Filipetto F, Zipp C, Coren J. Potential for Pregabalin Abuse or Diversion After Past Drug-Seeking Behavior case report. JAOA. 2010; 110(10):605-607.
Micromedex. Pregabalin. Drugpoint summary. Truven Health Analytics. 2014 Apr.
Nordgaard J, Jurgens G. A case of pregabalin abuse. Clin Toxicol. 2013; 51(4): 320.
Schifano F. Misuse and abuse of pregabalin and gabpentin: causefor concern? CNS Drugs. 2014; 28(6): 491-496.
Karosin C, Kofler M, Mayr A. Pregabalin: a treatment option for dystonia? Neurol Sci. 2012; 33(2): 351-354.
Oaklander A, Buchbinder B. Pregabalin withdrawal encephalopathy and splenial edema: a link to high altitude sickness? Ann Neurol. 2005; 58(2): 309-312.
Barret J, Kittler L, Singarajah C. Acute Pregabalin Withdrawal: A Case Report and Review of the Literature. Southwest Journal of Pulmonary and Critical Care. 2015; 10: 307- 310.
Baumgartner G, Rowen RC. Clonidina vs chlordiazepoxide in the management of acute alcohol withdrawal syndrome. Arch Intern Med. 1987.
Tolonen J, Rossinen J, Alho H, Harjola VP. Dexmedetomidina in addition to benzodiazepine
based sedation in patients with alcohol withdrawal delirium. Eur J Emerg Med. 2013; 20: 425-427.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.